Mouhamad Reslan

587 total citations
9 papers, 433 citations indexed

About

Mouhamad Reslan is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mouhamad Reslan has authored 9 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Mouhamad Reslan's work include Protein purification and stability (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Glycosylation and Glycoproteins Research (2 papers). Mouhamad Reslan is often cited by papers focused on Protein purification and stability (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Glycosylation and Glycoproteins Research (2 papers). Mouhamad Reslan collaborates with scholars based in Australia, Switzerland and United States. Mouhamad Reslan's co-authors include Veysel Kayser, Vicki Sifniotis, Esteban Cruz, Zehra Elgundi, Vijayaraghavan Ranganathan, Douglas R. MacFarlane, Bernhardt L. Trout, Yusuf K. Demir, Hak‐Kim Chan and Zeynep Sumer‐Bayraktar and has published in prestigious journals such as Advanced Drug Delivery Reviews, Chemical Communications and International Journal of Biological Macromolecules.

In The Last Decade

Mouhamad Reslan

9 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mouhamad Reslan Australia	7	261	187	83	58	55	9	433
Zhifen Li China	12	159 0.6×	32 0.2×	29 0.3×	26 0.4×	55 1.0×	48	523
Vicki Sifniotis Australia	6	217 0.8×	194 1.0×	7 0.1×	66 1.1×	63 1.1×	7	351
Esteban Cruz Australia	10	341 1.3×	279 1.5×	8 0.1×	131 2.3×	136 2.5×	20	650
Yosuke Terao Japan	12	252 1.0×	57 0.3×	10 0.1×	24 0.4×	19 0.3×	21	405
Wasfi Al‐Azzam Puerto Rico	14	343 1.3×	128 0.7×	4 0.0×	33 0.6×	56 1.0×	17	580
Jakob W. Buecheler Germany	11	141 0.5×	137 0.7×	5 0.1×	16 0.3×	105 1.9×	16	342
Malgorzata B. Tracka United States	9	398 1.5×	210 1.1×	5 0.1×	38 0.7×	15 0.3×	10	482
Bo Tan China	11	189 0.7×	19 0.1×	47 0.6×	131 2.3×	20 0.4×	25	650
Mary E. Krause United States	11	348 1.3×	178 1.0×	3 0.0×	32 0.6×	58 1.1×	26	524
Shinya Y. Sawata Japan	11	437 1.7×	41 0.2×	12 0.1×	7 0.1×	21 0.4×	17	511

Countries citing papers authored by Mouhamad Reslan

Since Specialization

Citations

This map shows the geographic impact of Mouhamad Reslan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mouhamad Reslan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mouhamad Reslan more than expected).

Fields of papers citing papers by Mouhamad Reslan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mouhamad Reslan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mouhamad Reslan. The network helps show where Mouhamad Reslan may publish in the future.

Co-authorship network of co-authors of Mouhamad Reslan

This figure shows the co-authorship network connecting the top 25 collaborators of Mouhamad Reslan. A scholar is included among the top collaborators of Mouhamad Reslan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mouhamad Reslan. Mouhamad Reslan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Cruz, Esteban, Vicki Sifniotis, Zeynep Sumer‐Bayraktar, et al.. (2021). Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity. Pharmaceutics. 13(11). 1747–1747. 2 indexed citations

2.

Reslan, Mouhamad, Vicki Sifniotis, Esteban Cruz, et al.. (2020). Enhancing the stability of adalimumab by engineering additional glycosylation motifs. International Journal of Biological Macromolecules. 158. 189–196. 13 indexed citations

3.

Reslan, Mouhamad, Vijayaraghavan Ranganathan, Douglas R. MacFarlane, & Veysel Kayser. (2018). Choline ionic liquid enhances the stability of Herceptin® (trastuzumab). Chemical Communications. 54(75). 10622–10625. 32 indexed citations

4.

Reslan, Mouhamad & Veysel Kayser. (2018). Ionic liquids as biocompatible stabilizers of proteins. Biophysical Reviews. 10(3). 781–793. 98 indexed citations

5.

Elgundi, Zehra, Vicki Sifniotis, Mouhamad Reslan, Esteban Cruz, & Veysel Kayser. (2017). Laboratory Scale Production and Purification of a Therapeutic Antibody. Journal of Visualized Experiments. 6 indexed citations

6.

Elgundi, Zehra, Vicki Sifniotis, Mouhamad Reslan, Esteban Cruz, & Veysel Kayser. (2017). Laboratory Scale Production and Purification of a Therapeutic Antibody. Journal of Visualized Experiments. 5 indexed citations

7.

Elgundi, Zehra, Mouhamad Reslan, Esteban Cruz, Vicki Sifniotis, & Veysel Kayser. (2016). The state-of-play and future of antibody therapeutics. Advanced Drug Delivery Reviews. 122. 2–19. 240 indexed citations

8.

Reslan, Mouhamad & Veysel Kayser. (2016). The effect of deuterium oxide on the conformational stability and aggregation of bovine serum albumin. Pharmaceutical Development and Technology. 23(10). 1030–1036. 22 indexed citations

9.

Reslan, Mouhamad, Yusuf K. Demir, Bernhardt L. Trout, Hak‐Kim Chan, & Veysel Kayser. (2016). Lack of a synergistic effect of arginine–glutamic acid on the physical stability of spray-dried bovine serum albumin. Pharmaceutical Development and Technology. 22(6). 785–791. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact